Physiological and Pharmaceutical Study of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus

Drug interactions have been studied by different group of researchers, in which they have used anumber of living organisms like humans and animals to reduce or inhibit risk of side effect of drugdisease interaction and enhance action of drugs.The present study was aimed to investigate the link of cardiovascular disease (CVD) includingatherosclerotic CVD (AsCVD), into patients with type 2 diabetes (T2D) that use sodium-glucoseco-transporter-2 inhibitors(SGLT2is) or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) aswell as to provide more information about the incidence of CVD in T2D patients. The current studyincluded 422 patients with T2D have diagnosed in Erbil, Kurdistan, Iraq, during their attended tosecondary care facilities. T2D patients were with the median age 66 years and median diabetesduration 13.3 years. Our results observed that the percentage of AsCVD was 27.2% of all cases ofCVD. The coronary heart disease recorded the highest percentage (20.8%) followed by carotidartery disease (12.1%).